![]() |
Revelation Biosciences, Inc. (RevB) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|

- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Revelation Biosciences, Inc. (REVB) Bundle
Diseñada para la precisión, nuestra calculadora DCF (RevB) le permite evaluar la valoración de Apocalipsis Biosciences, Inc. utilizando datos financieros del mundo real y ofrece una flexibilidad completa para modificar todos los parámetros esenciales para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue Growth, % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | .0 | -.1 | -11.9 | -10.8 | -.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EBITDA, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Depreciation | .2 | 3.8 | .1 | .0 | .0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
EBIT | -.2 | -3.9 | -12.0 | -10.9 | -.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Cash | .0 | 4.5 | 1.3 | 5.3 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .0 | .0 | .0 | .0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Account Receivables, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Inventories | .0 | .0 | .0 | .0 | .0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Inventories, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Accounts Payable | .0 | .9 | .6 | .6 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Accounts Payable, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Capital Expenditure | .0 | .0 | -.1 | .0 | .0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Capital Expenditure, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Rate, % | 0.00 | 0.00 | 0.00 | 0.92 | 0.00 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 |
EBITAT | -.2 | -3.9 | -12.0 | -10.8 | -.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.2 | 3.8 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Changes in Account Receivables | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |||||
Changes in Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |||||
Changes in Accounts Payable | -1.4 | 0.0 | 0.0 | 0.0 | 0.0 | |||||
Capital Expenditure | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
UFCF | .0 | .7 | -12.3 | -10.8 | .7 | -1.4 | 0.0 | 0.0 | 0.0 | 0.0 |
WACC, % | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 |
PV UFCF | -1.3 | |||||||||
SUM PV UFCF | -1.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0.0 | |||||||||
Terminal Value | 0.0 | |||||||||
Present Terminal Value | 0.0 | |||||||||
Enterprise Value | -1.3 | |||||||||
Net Debt | -12.0 | |||||||||
Equity Value | 10.7 | |||||||||
Diluted Shares Outstanding, MM | 0.0 | |||||||||
Equity Value Per Share | 0.00 |
What You Will Get
- Real REVB Financial Data: Pre-filled with Revelation Biosciences’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Revelation Biosciences’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: Gain access to reliable historical data and future forecasts tailored for Revelation Biosciences, Inc. (REVB).
- Adjustable Forecast Parameters: Modify highlighted cells such as WACC, growth rates, and profit margins to suit your analysis.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to help you visualize the valuation outcomes effectively.
- Designed for All Skill Levels: An intuitive layout catering to investors, CFOs, and consultants, whether seasoned or new.
How It Works
- Step 1: Download the Excel file for Revelation Biosciences, Inc. (REVB).
- Step 2: Review the pre-filled financial data and forecasts for REVB.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose Revelation Biosciences, Inc. (REVB) Calculator?
- Comprehensive Analysis: Offers in-depth evaluations including DCF, WACC, and essential financial ratios.
- Flexible Parameters: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Revelation Biosciences.
- Integrated Data: Access to historical and projected data for reliable analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and business consultants focusing on biotechnology.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for biotechnology investments.
- Corporate Development Teams: Evaluate valuation scenarios to shape strategic initiatives within the company.
- Consultants and Advisors: Offer clients precise valuation insights for Revelation Biosciences, Inc. (REVB).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech firms like Revelation Biosciences, Inc. (REVB) are assessed in the market.
What the Template Contains
- Pre-Filled Data: Contains Revelation Biosciences, Inc.'s (REVB) historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations for REVB.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on tailored inputs.
- Key Financial Ratios: Evaluate REVB's profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily adjust revenue growth, profit margins, and tax rates.
- Clear Dashboard: Visuals and tables summarizing essential valuation outcomes for REVB.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.